1. Home
  2. WST vs BR Comparison

WST vs BR Comparison

Compare WST & BR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • BR
  • Stock Information
  • Founded
  • WST 1923
  • BR 1962
  • Country
  • WST United States
  • BR United States
  • Employees
  • WST N/A
  • BR N/A
  • Industry
  • WST Medical/Dental Instruments
  • BR Business Services
  • Sector
  • WST Health Care
  • BR Consumer Discretionary
  • Exchange
  • WST Nasdaq
  • BR Nasdaq
  • Market Cap
  • WST 18.9B
  • BR 29.9B
  • IPO Year
  • WST N/A
  • BR 2007
  • Fundamental
  • Price
  • WST $257.33
  • BR $245.95
  • Analyst Decision
  • WST Strong Buy
  • BR Buy
  • Analyst Count
  • WST 8
  • BR 7
  • Target Price
  • WST $329.43
  • BR $261.50
  • AVG Volume (30 Days)
  • WST 549.8K
  • BR 607.1K
  • Earning Date
  • WST 10-23-2025
  • BR 11-04-2025
  • Dividend Yield
  • WST 0.34%
  • BR 1.59%
  • EPS Growth
  • WST N/A
  • BR 21.16
  • EPS
  • WST 6.68
  • BR 7.10
  • Revenue
  • WST $2,960,200,000.00
  • BR $6,889,100,000.00
  • Revenue This Year
  • WST $6.28
  • BR $8.11
  • Revenue Next Year
  • WST $6.02
  • BR $5.13
  • P/E Ratio
  • WST $38.69
  • BR $34.55
  • Revenue Growth
  • WST 2.90
  • BR 5.88
  • 52 Week Low
  • WST $187.43
  • BR $207.21
  • 52 Week High
  • WST $352.33
  • BR $271.91
  • Technical
  • Relative Strength Index (RSI)
  • WST 58.88
  • BR 38.51
  • Support Level
  • WST $254.35
  • BR $244.91
  • Resistance Level
  • WST $264.06
  • BR $255.74
  • Average True Range (ATR)
  • WST 5.88
  • BR 4.13
  • MACD
  • WST 0.45
  • BR -1.19
  • Stochastic Oscillator
  • WST 69.98
  • BR 7.51

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About BR Broadridge Financial Solutions Inc.

Broadridge Financial Solutions, which was spun off from Automatic Data Processing in 2007, is a leading provider of investor communication and technology-driven solutions to banks, broker/dealers, traditional and alternative-asset managers, wealth managers, and corporate issuers. Broadridge is composed of two operating segments: investor communication solutions and global technology and operations.

Share on Social Networks: